Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Intersect ENT, Inc.XENT · Entity 127294 | Chief Human Resource Officer | May 13, 2022 | May 16, 2022 |
| iRhythm Holdings, Inc.IRTC · Entity 1499 | EVP, Chief HR Officer | February 27, 2023 | March 01, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Intersect ENT, Inc.
Report date May 13, 2022 · Filed May 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-05-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-05-13 · Other · Disposed 28,165 · Balance 3,411 F1: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to vesting conditions based solely on continued employment with or service to the Company or any of its subsidiaries (each, an 'Issuer RSU') that was outstanding and unvested immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer RSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes. Row 2 · 2022-05-13 · Other · Disposed 3,411 · Balance 0 F2: Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the 'Merger Agreement'), dated August 6, 2021, by and among the Issuer, Medtronic, Inc. ('Parent') and Project Kraken Merger Sub, Inc., a wholly-owned subsidiary of Parent ('Merger Sub'), including the consummation of the merger (the 'Merger') between Issuer and Merger Sub on May 13, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the 'Effective Time'), [each outstanding share of Issuer common stock, $0.001 par value per share ('Issuer Common Stock'), was cancelled, retired and converted into the right to receive an amount equal to $28.25 in cash, without interest thereon (the 'Common Stock Merger Consideration'), subject to any required withholding of taxes]. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.89 · Expires 2030-12-01 | Direct | 0 |
Reported balance
After 2022-05-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-13 · Other · Disposed 29,993 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to vesting conditions based solely on continued employment with or service to the Company or any of its subsidiaries (each, an 'Issuer RSU') that was outstanding and unvested immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer RSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes.
F2: Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the 'Merger Agreement'), dated August 6, 2021, by and among the Issuer, Medtronic, Inc. ('Parent') and Project Kraken Merger Sub, Inc., a wholly-owned subsidiary of Parent ('Merger Sub'), including the consummation of the merger (the 'Merger') between Issuer and Merger Sub on May 13, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the 'Effective Time'), [each outstanding share of Issuer common stock, $0.001 par value per share ('Issuer Common Stock'), was cancelled, retired and converted into the right to receive an amount equal to $28.25 in cash, without interest thereon (the 'Common Stock Merger Consideration'), subject to any required withholding of taxes].
F3: Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes.
iRhythm Holdings, Inc.
Report date February 27, 2023 · Filed March 01, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,615 |
Reported balance
After 2023-02-27 transaction · row 1
1 source rowRow 1 · 2023-02-27 · Grant · Acquired 6,961 · Balance 14,615 F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2024 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2024 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2023 Filed Mar 1, 2023 18:01 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 6,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-23-000011 · wf-form4_167771167374263.xml · nonDerivative · entry 1 Fernandez Reyna M · CIK 0001834256 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,615 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2024 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 16:12 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 7,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-22-000113 · wf-form4_165895275868957.xml · nonDerivative · entry 1 Fernandez Reyna M · CIK 0001834256 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,559 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on August 1, 2023 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| July 25, 2022 Filed Nov 21, 2022 11:02 UTC Amendment | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 7,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-22-000163 · wf-form4a_166904654263226.xml · nonDerivative · entry 1 Fernandez Reyna M · CIK 0001834256 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,654 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on August 1, 2023 and each one-yearanniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. F2 · acquired: The acquisition of 95 shares was omitted from the Reporting Person's original Form 4, filed July 27, 2022. Read SEC document |
| May 13, 2022 Filed May 16, 2022 18:41 UTC | Intersect ENT, Inc. XENT · Entity 127294 | OtherStock Options (Right to buy) · Derivative | 29,993 | $28.25 Strike: $19.89 | $847,302.25 |
DisclosureSEC source: 0001562180-22-004075 · primarydocument.xml · derivative · entry 3 Fernandez Reyna M · CIK 0001834256 · Chief Human Resource Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,993 shares Expires 2030-12-01 F3 · kind: Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes. F3 · price: Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes. Read SEC document |
| May 13, 2022 Filed May 16, 2022 18:41 UTC | Intersect ENT, Inc. XENT · Entity 127294 | OtherCommon Stock | 3,411 | $28.25 | $96,360.75 |
DisclosureSEC source: 0001562180-22-004075 · primarydocument.xml · nonDerivative · entry 2 Fernandez Reyna M · CIK 0001834256 · Chief Human Resource Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the 'Merger Agreement'), dated August 6, 2021, by and among the Issuer, Medtronic, Inc. ('Parent') and Project Kraken Merger Sub, Inc., a wholly-owned subsidiary of Parent ('Merger Sub'), including the consummation of the merger (the 'Merger') between Issuer and Merger Sub on May 13, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the 'Effective Time'), [each outstanding share of Issuer common stock, $0.001 par value per share ('Issuer Common Stock'), was cancelled, retired and converted into the right to receive an amount equal to $28.25 in cash, without interest thereon (the 'Common Stock Merger Consideration'), subject to any required withholding of taxes]. F2 · price: Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the 'Merger Agreement'), dated August 6, 2021, by and among the Issuer, Medtronic, Inc. ('Parent') and Project Kraken Merger Sub, Inc., a wholly-owned subsidiary of Parent ('Merger Sub'), including the consummation of the merger (the 'Merger') between Issuer and Merger Sub on May 13, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the 'Effective Time'), [each outstanding share of Issuer common stock, $0.001 par value per share ('Issuer Common Stock'), was cancelled, retired and converted into the right to receive an amount equal to $28.25 in cash, without interest thereon (the 'Common Stock Merger Consideration'), subject to any required withholding of taxes]. Read SEC document |
| May 13, 2022 Filed May 16, 2022 18:41 UTC | Intersect ENT, Inc. XENT · Entity 127294 | OtherCommon Stock | 28,165 | $28.25 | $795,661.25 |
DisclosureSEC source: 0001562180-22-004075 · primarydocument.xml · nonDerivative · entry 1 Fernandez Reyna M · CIK 0001834256 · Chief Human Resource Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,411 F1 · kind: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to vesting conditions based solely on continued employment with or service to the Company or any of its subsidiaries (each, an 'Issuer RSU') that was outstanding and unvested immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer RSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes. F1 · price: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to vesting conditions based solely on continued employment with or service to the Company or any of its subsidiaries (each, an 'Issuer RSU') that was outstanding and unvested immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer RSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:20 UTC | Intersect ENT, Inc. XENT · Entity 127294 | GrantCommon Stock | 17,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001103 · primarydocument.xml · nonDerivative · entry 1 Fernandez Reyna M · CIK 0001834256 · Chief Human Resource Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,576 F1 · security: Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the Vesting Commencement Date of February 1, 2022. F2 · balance_after: Includes 28,165 Restricted stock units. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 19:12 UTC | Intersect ENT, Inc. XENT · Entity 127294 | Tax withholdingCommon Stock | 1,957 | $26.91 | $52,657.39 |
DisclosureSEC source: 0001562180-21-007464 · primarydocument.xml · nonDerivative · entry 1 Fernandez Reyna M · CIK 0001834256 · Chief Human Resource Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,147 F1 · shares: Shares tendered in payment of the tax withholding obligation in compliance and as required by the company's equity documents. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.83 to $27.06, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · balance_after: Includes 10,736 restricted stock units. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:56 UTC | Intersect ENT, Inc. XENT · Entity 127294 | GrantStock Options (Right to buy) · Derivative | 29,993 | $0.00 Strike: $19.89 | $0.00 |
DisclosureSEC source: 0001562180-20-007086 · primarydocument.xml · derivative · entry 2 Fernandez Reyna M · CIK 0001834256 · Chief Human Resource Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,993 Underlying: Common Stock · 29,993 shares Expires 2030-12-01 F3 · derivative.exercise_date: The vesting commencement date of the option is November 30, 2020. 1/4th of the shares subject to the option shall vest on November 30, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter over 36 months. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:56 UTC | Intersect ENT, Inc. XENT · Entity 127294 | GrantCommon Stock | 16,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007086 · primarydocument.xml · nonDerivative · entry 1 Fernandez Reyna M · CIK 0001834256 · Chief Human Resource Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,104 F1 · security: Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the Vesting Commencement Date of November 30, 2020. F2 · balance_after: Restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.